RAMAKRISHNAN C V, BHATIA A L, FOX W, MITCHISON D A, RADHAKRISHNA S, SELKON J B, SELKON J B, SUBBAIAH T V, VELU S, WALLACE J G
Bull World Health Organ. 1961;25(3):323-38.
This is the last of a series of three reports from the Tuberculosis Chemotherapy Centre Madras, on a study undertaken with the object of finding out whether differences in the virulence in the guinea-pig of tubercle bacilli isolated from South Indian tuberculous patients before the start of chemotherapy are related to the severity of the patients' disease on admission to treatment and to the subsequent response to chemotherapy. The 281 patients in this study were drawn from the patients admitted to a 1-year comparison of four domiciliary chemotherapeutic regimens: (a) 3.9-5.5 mg/kg isoniazid plus 0.2-0.3 g/kg sodium PAS daily, divided into two doses (PH series); (b) 7.8-9.6 mg/kg isoniazid alone daily in one dose (HI-1 series); (c) 7.8-9.6 mg/kg isoniazid alone daily, divided into two doses (HI-2 series); (d) 3.9-5.5 mg/kg isoniazid alone daily, divided into two doses (H series).No evidence was found of an association between the virulence of the organisms and any pretreatment condition of known prognostic importance. There was no association between pretreatment virulence and progress during treatment in the PH series (the most effective regimen). In the other series, however, the progress was more satisfactory in patients infected with organisms of low virulence than in those infected with organisms of high virulence, the association between virulence and progress attaining statistical significance in the combined HI-2 and H series (the least effective regimens) and only just failing to do so in the smaller HI-1 series.Possible explanations are put forward both for the absence of an association between virulence and severity of disease on admission and for the presence of an association between virulence and response in the patients treated with isoniazid alone.
这是马德拉斯结核病化疗中心发布的系列三份报告中的最后一份。该研究旨在确定化疗开始前从南印度结核病患者分离出的结核杆菌在豚鼠体内的毒力差异,是否与患者入院治疗时疾病的严重程度以及随后对化疗的反应有关。本研究中的281名患者来自于一项为期1年的四种家庭化疗方案对比研究的受试患者:(a)3.9 - 5.5毫克/千克异烟肼加0.2 - 0.3克/千克对氨基水杨酸钠,每日分两次服用(PH系列);(b)7.8 - 9.6毫克/千克异烟肼,每日一次服用(HI - 1系列);(c)7.8 - 9.6毫克/千克异烟肼,每日分两次服用(HI - 2系列);(d)3.9 - 5.5毫克/千克异烟肼,每日分两次服用(H系列)。未发现生物体毒力与任何已知预后重要性的预处理条件之间存在关联。在PH系列(最有效的方案)中,预处理毒力与治疗期间的病情进展之间没有关联。然而,在其他系列中,感染低毒力生物体的患者比感染高毒力生物体的患者病情进展更令人满意,毒力与病情进展之间的关联在合并的HI - 2和H系列(最无效的方案)中达到统计学显著性,而在较小的HI - 1系列中仅略未达到。对于毒力与入院时疾病严重程度之间缺乏关联以及单独使用异烟肼治疗的患者中毒力与反应之间存在关联,都提出了可能的解释。